Clinical Trial Update: A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating the combination of prexasertib, irinotecan, and temozolomide in Desmoplastic Small Round Cell Tumor and rhabdomyosarcoma has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoplastic Small Round Cell Tumor
• Rhabdomyosarcoma

Drugs mentioned

• Camptosar (irinotecan)
• Prexasertib (prexasertib)
• Temodar (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Desmoplastic Small Round Cell Tumor, Rhabdomyosarcoma | Phase 1, Phase 2 | Status: COMPLETED